SCHEMBL973109

SCHEMBL973109

Brc1c(-c2ccccc2)nc2ccccn12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.64
RAB9A P51151 4/20 0.64
KDM4E B2RXH2 4/20 0.57
MAPT P10636 2/20 0.57
ADRA1B P35368 1/20 0.54
NTRK1 P04629 1/20 0.54
ALDH1A1 P00352 5/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
PKM P14618 1/20 0.49
ATM Q13315 1/20 0.49
GLA P06280 1/20 0.48
GAA P10253 1/20 0.48
CASP1 P29466 1/20 0.48
CASP7 P55210 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
AKT1 P31749 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8873874 0.89 NPC1 (0.71) NPC1RAB9AKDM4EMAPTADRA1B
SCHEMBL28669282 0.86 KDM4E (0.58) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL18221717 0.86 NPC1 (0.63) NPC1RAB9AKDM4EMAPTADRA1B
SCHEMBL15825411 0.86 ALDH1A1 (0.62) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL25790023 0.85 KDM4E (0.57) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL8873145 0.82 RAB9A (0.70) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL4507982 0.82 NPC1 (0.55) NPC1RAB9AKDM4EMAPTADRA1B
SCHEMBL18203556 0.82 RAB9A (0.51) NPC1RAB9AKDM4EMAPTALDH1A1
SCHEMBL1428632 0.82 NPC1 (0.55) NPC1RAB9AKDM4EMAPTNTRK1
SCHEMBL25790039 0.82 NPC1 (0.52) NPC1RAB9AKDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113861192-A Preparation method of C-3 halogenated imidazo [1,2-a ] pyridine derivative 郑州大学 2021-12-31 CN disclosed
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 US disclosed
WO-2019190184-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2019-10-03 WO disclosed
WO-2019155363-A1 BENZO-IMIDAZOINDOLIZINE DERIVATIVE, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL USING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2019-08-15 WO disclosed
WO-2019155363-A1 BENZO-IMIDAZOINDOLIZINE DERIVATIVE, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL USING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE USING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2019-08-15 WO disclosed
EP-3524607-A1 BENZO-IMIDAZOINDOLIZINE DERIVATIVE, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL USING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2019-08-14 EP disclosed
EP-3524607-A1 BENZO-IMIDAZOINDOLIZINE DERIVATIVE, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL USING THE SAME, AND ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE USING THE SAME Idemitsu Kosan Co., Ltd. (JP) 2019-08-14 EP disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 US disclosed
WO-2016003171-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME 희성소재(주) 2016-01-07 WO disclosed
US-7867629-B2 Nitrogenous heterocyclic derivative and organic electroluminescent element employing the same IDEMITSU KOSAN CO., LTD. (JP) 2011-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 NPC1 4161/4885RAB9A 3177/4885KDM4E 1869/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 NPC1 4161/4885RAB9A 3177/4885KDM4E 1869/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.